In a move that psychologists and psychiatrists are calling "concerning," popular genetics company 23andMe launched an initiative earlier this month allowing customers to share tips about which treatments for conditions including ADHD and depression do or don't work for them...But experts warn that some aspects of the crowdsourcing initiative could be dangerously misleading and even discourage people from getting treatments that are recommended to them by physicians.